title: Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein.
abstract: Intrinsic immunity relies on specific recognition of viral epitopes to mount a cell-autonomous defense against viral infections. Viral recognition determinants in intrinsic immunity genes are expected to evolve rapidly as host genes adapt to changing viruses, resulting in a signature of adaptive evolution. Zinc-finger antiviral protein (ZAP) from rats was discovered to be an intrinsic immunity gene that can restrict murine leukemia virus, and certain alphaviruses and filoviruses. Here, we used an approach combining molecular evolution and cellular infectivity assays to address whether ZAP also acts as a restriction factor in primates, and to pinpoint which protein domains may directly interact with the virus. We find that ZAP has evolved under positive selection throughout primate evolution. Recurrent positive selection is only found in the poly(ADP-ribose) polymerase (PARP)-like domain present in a longer human ZAP isoform. This PARP-like domain was not present in the previously identified and tested rat ZAP gene. Using infectivity assays, we found that the longer isoform of ZAP that contains the PARP-like domain is a stronger suppressor of murine leukemia virus expression and Semliki forest virus infection. Our study thus finds that human ZAP encodes a potent antiviral activity against alphaviruses. The striking congruence between our evolutionary predictions and cellular infectivity assays strongly validates such a combined approach to study intrinsic immunity genes.
authors.affiliation: Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
authors.forename: Julie A
authors.initials: JA
authors.lastname: Kerns
authors.forename: Michael
authors.initials: M
authors.lastname: Emerman
authors.forename: Harmit S
authors.initials: HS
authors.lastname: Malik
mesh_terms: D018354:Alphavirus Infections / Q000821:virology; D000595:Amino Acid Sequence; D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism*; D002352:Carrier Proteins / Q000737:chemistry* / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D016013:Likelihood Functions; D008969:Molecular Sequence Data; D010802:Phylogeny; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism*; D011323:Primates; D020033:Protein Isoforms / Q000737:chemistry / Q000378:metabolism; D017434:Protein Structure, Tertiary; D016601:RNA-Binding Proteins / Q000737:chemistry* / Q000378:metabolism*; D051381:Rats; D012641:Selection, Genetic; D012672:Semliki forest virus; D013045:Species Specificity
chemical_list: D000998:Antiviral Agents; D002352:Carrier Proteins; D020033:Protein Isoforms; D016601:RNA-Binding Proteins; C527496:ZC3HAV1 protein, human; D011065:Poly(ADP-ribose) Polymerases